We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AdvaMed Letter Pushes for Diagnostic Reform in FDA User Fee Reauthorization
AdvaMed Letter Pushes for Diagnostic Reform in FDA User Fee Reauthorization
Medical device trade group AdvaMed and dozens of diagnostics and device firms are urging Congress to include diagnostics reform provisions in the FDA user fee reauthorization package that is currently awaiting a Senate vote.